Search research articles
Contact Us
Filters
Showing results (111-120 of 177) with videos related to
Page
of 18
Sort By:
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
August 8, 2025
PAVFCOS: The development of a core outcome set for pouch anal and vaginal fistula
Lillian Reza, Lara Bapir, Nusrat Iqbal, et al.
Journal of Crohn'S & Colitis
|
August 16, 2023
Defining Comprehensive Disease Control for Use as a Treatment Target for Ulcerative Colitis in Clinical Practice: International Delphi Consensus Recommendations
Stefan Schreiber, Silvio Danese, Axel Dignass, et al.
United European Gastroenterology Journal
|
May 9, 2026
Effect of Mirikizumab on Clinical and Endoscopic Outcomes Based on Prior Advanced Therapy Failure in Patients With Moderately to Severely Active Ulcerative Colitis
Ailsa Hart, Seyedehsan Navabi, Geert D'Haens, et al.
Journal of Crohn'S & Colitis
|
January 31, 2016
Results of the Fifth Scientific Workshop of the ECCO [II]: Clinical Aspects of Perianal Fistulising Crohn's Disease-the Unmet Needs
Krisztina B Gecse, Shaji Sebastian, Gert de Hertogh, et al.
Gut
|
May 15, 2021
Multicentre derivation and validation of a colitis-associated colorectal cancer risk prediction web tool
Kit Curtius, Misha Kabir, Ibrahim Al Bakir, et al.
The Lancet. Gastroenterology & Hepatology
|
November 19, 2021
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial
Laurent Peyrin-Biroulet, Ailsa Hart, Peter Bossuyt, et al.
The Patient
|
January 31, 2020
A Qualitative Research for Defining Meaningful Attributes for the Treatment of Inflammatory Bowel Disease from the Patient Perspective
Edouard Louis, Juan M Ramos-Goñi, Jesus Cuervo, et al.
Autoimmunity Reviews
|
May 11, 2021
Biobetters in patients with immune-mediated inflammatory disorders: An international Delphi consensus
Ferdinando D'Amico, Virginia Solitano, Daniel Aletaha, et al.
Gut
|
June 25, 2019
Cost-effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn's disease: the LIR!C Trial
E Joline de Groof, Toer W Stevens, Emma J Eshuis, et al.
Alimentary Pharmacology & Therapeutics
|
April 2, 2019
Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients
Lieven Pouillon, Silvio Danese, Ailsa Hart, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 177) with videos related to
Sort By:
Page
of 18
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
August 8, 2025
PAVFCOS: The development of a core outcome set for pouch anal and vaginal fistula
Lillian Reza, Lara Bapir, Nusrat Iqbal, et al.
Journal of Crohn'S & Colitis
|
August 16, 2023
Defining Comprehensive Disease Control for Use as a Treatment Target for Ulcerative Colitis in Clinical Practice: International Delphi Consensus Recommendations
Stefan Schreiber, Silvio Danese, Axel Dignass, et al.
United European Gastroenterology Journal
|
May 9, 2026
Effect of Mirikizumab on Clinical and Endoscopic Outcomes Based on Prior Advanced Therapy Failure in Patients With Moderately to Severely Active Ulcerative Colitis
Ailsa Hart, Seyedehsan Navabi, Geert D'Haens, et al.
Journal of Crohn'S & Colitis
|
January 31, 2016
Results of the Fifth Scientific Workshop of the ECCO [II]: Clinical Aspects of Perianal Fistulising Crohn's Disease-the Unmet Needs
Krisztina B Gecse, Shaji Sebastian, Gert de Hertogh, et al.
Gut
|
May 15, 2021
Multicentre derivation and validation of a colitis-associated colorectal cancer risk prediction web tool
Kit Curtius, Misha Kabir, Ibrahim Al Bakir, et al.
The Lancet. Gastroenterology & Hepatology
|
November 19, 2021
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial
Laurent Peyrin-Biroulet, Ailsa Hart, Peter Bossuyt, et al.
The Patient
|
January 31, 2020
A Qualitative Research for Defining Meaningful Attributes for the Treatment of Inflammatory Bowel Disease from the Patient Perspective
Edouard Louis, Juan M Ramos-Goñi, Jesus Cuervo, et al.
Autoimmunity Reviews
|
May 11, 2021
Biobetters in patients with immune-mediated inflammatory disorders: An international Delphi consensus
Ferdinando D'Amico, Virginia Solitano, Daniel Aletaha, et al.
Gut
|
June 25, 2019
Cost-effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn's disease: the LIR!C Trial
E Joline de Groof, Toer W Stevens, Emma J Eshuis, et al.
Alimentary Pharmacology & Therapeutics
|
April 2, 2019
Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients
Lieven Pouillon, Silvio Danese, Ailsa Hart, et al.
Page
of 18